Martina Konantz
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Fedratinib and gandotinib induce apoptosis and enhance the efficacy of tyrosine kinase inhibitors in human mast cells.
Journal: American journal of cancer research
Published: October 22, 2024
Post-transplant Inflammatory Bowel Disease Associated with Donor-Derived TIM-3 Deficiency.
Journal: Journal of clinical immunology
Published: August 21, 2023
Increased TIM-3 and galectin-9 serum levels in patients with advanced systemic mastocytosis.
Journal: The Journal of allergy and clinical immunology
Published: May 15, 2023
MRGPRX2: A novel biomarker in mastocytosis?
Journal: The journal of allergy and clinical immunology. In practice
Published: September 30, 2022
Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers.
Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers.
Journal: Communications biology
Published: July 05, 2022
Presence of neoplastic mast cells in ascites in advanced systemic mastocytosis.
Journal: The journal of allergy and clinical immunology. In practice
Published: March 24, 2022
Glycosphingolipids are mediators of cancer plasticity through independent signaling pathways.
Journal: Cell reports
Published: February 04, 2022
Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia.
Journal: Journal of visualized experiments : JoVE
Published: March 08, 2021
Biodegradable Harmonophores for Targeted High-Resolution In Vivo Tumor Imaging.
Journal: ACS nano
Published: February 25, 2021
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers.
Journal: Communications biology
Published: January 07, 2021
Last Updated: 09/26/2026